Retinoblastoma - Pipeline Review, H2 2020

Published	Pages	Publisher	Report code
Oct 2020	72	Global Markets Direct	ASDR-567846

Published: Oct 2020 - Pages : 72 - Publisher : Global Markets Direct - Report code : ASDR-567846

Aileron Therapeutics Inc
APEIRON Biologics AG
Canget BioTekpharma LLC
Innovation Pharmaceuticals Inc
Oxular Ltd
PepVax Inc
Seneca Therapeutics Inc
Targeted Therapy Technologies LLC
VCN Biosciences SL
Y-mAbs Therapeutics Inc

Retinoblastoma Treatment Market Size - By Disease Type (Non-hereditary, Hereditary), Disease Stage (Intraocular, Extraocular), Treatment Type (Chemotherapy, Radiation, Surgery, Laser, Cryotherapy), End-user & Global Forecast, 2024 - 2032

This report can be of interest as well:

Retinoblastoma Treatment Market Size - By Disease Type (Non-hereditary, Hereditary), Disease Stage (Intraocular, Extraoc...

Published: December, 2023 | Report code: ASDR-654418